Protein A - 10nm Silver Conjugate
Cytodiagnostics
SKU:SC-10-05-05
Couldn't load pickup availability

Protein A - 10nm Silver Conjugate for silver nanoparticle detection
Protein A - 10nm Silver Conjugate is a silver nanoparticle conjugate for detecting compatible immunoglobulins through Protein A binding in Immunoblotting, Light Microscopy and Electron Microscopy. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Where it helps
The silver nanoparticle label is useful when a bright silver-based optical readout is preferred over a traditional gold readout. The smaller silver label can be useful when epitope access, membrane flow or reduced steric load are important.
Planning the experiment
- Helps connect Protein A recognition to Immunoblotting, Light Microscopy and Electron Microscopy while keeping the experimental purpose clear for protocol planning.
- Useful when the primary antibody class is compatible with Protein A binding and a species-independent detection strategy is desired.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference SC-10-05-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. For protocol transfer, record the catalog reference together with the selected application and control strategy.
- Research Area:
- Bioconjugation & Labeling • Assay Development • Nanotechnology & Biosensors
- Application:
- Immunoblotting • Light Microscopy • Electron Microscopy
- Host:
- S. Aureus
- Formulation:
- 1XPBS (pH 7.4), 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 390-405nm
- Core Size:
- 10nm
- Shape:
- Spherical
- Material:
- Silver
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.